“Comparison of Fundus Autofluorescence Images to Digital Color Images for RPE Atrophy in AREDS2”, in Annual Meeting, Association for Research in Vision and Ophthalmology (ARVO), Fort Lauderdale, FL, 2008.
“Improvement in Outcomes of Clinical Islet Transplantation: 1999-2010”, in 72nd Scientific Sessions of the American Diabetes Association, Philadelphia, PA, 2012.
, “Keystone Symposia Global Health Series: Pathogenesis and Control of Emerging Infections and Drug Resistant Organisms”, presented at the 2008, Bangkok, Thailand, 2008.
, “ABO-Blood Groups and Risk of Abdominal Aortic Aneurysm and Peripheral Obstructive Artery Disease: Two Sides of the Same Coin”, Thromb Res, vol. 129, pp. 89-90, 2012.
, “Safety and Immunogenicity of Modified Vaccinia Ankara in Hematopoietic Stem Cell Transplant Recipients: A Randomized, Controlled Trial”, J Infect Dis, vol. 207, pp. 1888-1897, 2013.
, “Total Colony-Forming Units Are a Strong, Independent Predictor of Neutrophil and Platelet Engraftment After Unrelated Umbilical Cord Blood Transplantation: A Single-Center Analysis of 435 Cord Blood Transplants”, Biol Blood Marrow Transplant, vol. 17, pp. 1362-1374, 2011.
, “Background Morbidity in HIV Vaccine Trial Participants From Various Geographic Regions as Assessed by Unsolicited Adverse Events”, Hum Vaccin Immunother, vol. 8, pp. 630-638, 2012.
“Lessons from IAVI-006, a Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of the PTHR.HIVA DNA and MVA.HIVA Vaccines in a Prime-Boost Strategy to Induce HIV-1 Specific T-Cell Responses in Healthy Volunteers”, Vaccine, vol. 26, pp. 6671-6677, 2008.
, “Clinical trials referral resource. Clinical trials in elderly patients.”, Oncology, vol. 11, pp. 838-44, 1997.
, “Clinical trials referral resource. Clinical trials with PSC-833”, Oncology, vol. 11, pp. 490-3, 1997.
, “Retrospective Studies: A Fresh Look.”, Am J Speech Lang Pathol, vol. 25, no. 2, pp. 157-63, 2016.
, “Evaluation of the Mercy TAPE: performance against the standard for pediatric weight estimation.”, Ann Emerg Med, vol. 62, no. 4, pp. 332-339.e6, 2013.
, “Validation and human factor analysis study of an infant weight estimation device.”, BMC Pediatr, vol. 20, no. 1, p. 30, 2020.
, “Evaluation of the Mercy TAPE: Performance Against the Standard for Pediatric Weight”, Ann Emerg Med, vol. 62, pp. 332-339.e6, 2013.
, “Patient-Reported Outcomes and Frailty Among Participants in the NHLBI MDS Natural History Study”, in 62nd ASH Annual Meeting and Exposition, 2020.
, “Patient-Reported Outcomes and Frailty Among Participants in the NHLBI MDS Natural History Study”, in American Society of Hematology (ASH), 2020.
, “Health-related quality of life and vulnerability among people with myelodysplastic syndromes: a US national study”, Blood Adv, vol. 7, no. 14, pp. 3506-3515, 2023.
, “Clinical trials referral resource. Current phase III, NCI-supported, Cooperative Group Clinical Trials in breast cancer.”, Oncology (Williston Park), vol. 18, no. 4, pp. 463-4, 467-8, 470, 2004.
, “Paclitaxel Activity in Heavily Pretreated Breast Cancer: A National Cancer Institute Treatment Referral Center Trial”, J Clin Oncol, vol. 13, pp. 2056-2065, 1995.
, “Meeting Highlights: A Reappraisal of Research Results For the Local Treatment of Early Stage Breast Cancer”, J Natl Cancer Inst, vol. 87, pp. 1837-1845, 1995.
, “Paclitaxel activity in heavily pretreated breast cancer: a National Cancer Institute Treatment Referral Center trial.”, J Clin Oncol, vol. 13, no. 8, pp. 2056-65, 1995.
, “Meeting highlights: a reappraisal of research results for the local treatment of early stage breast cancer.”, J Natl Cancer Inst, vol. 87, no. 24, pp. 1837-45, 1995.
, “Current Cooperative Group phase III clinical trials in early stage breast cancer”, Oncology, vol. 15, pp. 52-56, 2001.
, “Clinical trials referral resource. Current cooperative group phase III clinical trials in early-stage breast cancer.”, Oncology (Williston Park), vol. 15, no. 2, pp. 176-7, 181-2, 185, 2001.
, ,